Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trial pipeline

9 trials changed in the last 30 days: 2 stopped, 4 with notable changes, 3 with minor changes only.

1. Stopped

   LVIVO-TaVec400 · Relapsed/Refractory Autoimmune Diseases

   Withdrawn before enrolling

   Sponsor's reason: pipeline strategy change

   Also in this update: Primary completion date changed from estimate of Sep 20, 2028 to Sep 23, 2026

   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·Early Phase 1· NCT07583030· Registry history of NCT07583030 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

2. Stopped

   Immunoinflammatory Regulation of Esketamine in Septic Patients

   Trial terminated

   Sponsor's reason: Due to changes in the study plan, no significant clinical benefit was observed, but no adverse events occurred either.

   Also in this update: Final enrollment: 10 participants (planned 100); Primary completion date changed from estimate of Oct 30, 2026 to Jan 1, 2026

   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 4· NCT04843982· Registry history of NCT04843982 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

3. Notable

   Serplulimab Combined With Induction Chemotherapy and Radiotherapy…Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma

   Primary and study completion pushed from Dec 31, 2031 to Dec 31, 2035

   Also in this update: Primary endpoint(s) modified; Recruitment opened

   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 3· NCT07177443· Registry history of NCT07177443 on ClinicalTrials.gov (opens the registry)

   Updated Sep 17, 2026

4. Notable

   Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without…Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy · CRCLM

   Recruitment opened

   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 2· NCT07728019· Registry history of NCT07728019 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

5. Notable

   Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and…Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

   Recruitment opened

   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 2· NCT07776080· Registry history of NCT07776080 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

6. Notable

   Metabolic and Functional Study of γδ T Cells in Critically Ill…Metabolic and Functional Study of γδ T Cells in Critically Ill Patients

   Recruitment opened

   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·Not specified· NCT07680816· Registry history of NCT07680816 on ClinicalTrials.gov (opens the registry)

   Updated Sep 17, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.